HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dea, M. K. Articles by Bergman, R. N. Search for Related Content PubMed PubMed Citation Articles by Dea, M. K. Articles by Bergman, R. N. Social Bookmarking                What's this?

Albumin Binding of Acylated Insulin (NN304) Does Not Deter Action to Stimulate Glucose Uptake

¹ Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles, California
² Novo Research Institute, Novo Nordisk A/S, Bagsvaerd, Denmark

NN304 [Lys^B29-tetradecanoyl des(B30) human insulin] is a potentially therapeutic insulin analog designed to exhibit protracted glucose-lowering action. In dogs with infusion rates similar to insulin itself, NN304 exhibits similar glucose uptake (R_d) stimulation with delayed onset of action. This compartmental modeling study was to determine if NN304 action could be accounted for by the 2% unbound NN304 concentration. NN304 (or human insulin) (n = 6 each) was infused at 10.2 pmol · min^-1 · kg^-1 under euglycemic clamp conditions in anesthetized dogs. NN304 appearance in lymph, representing interstitial fluid (ISF), was slow compared with insulin (t_1/2 = 70 ± 7 vs. 14 ± 1 min, P < 0.001). R_d was highly correlated with the ISF concentration for insulin and NN304 (r = 0.86 and 0.93, respectively), suggesting that slow transendothelial transport (TET) is responsible for sluggish NN304 action. Insulin and NN304 concentration data were fit to a two-compartment (plasma and ISF) model. NN304 plasma elimination and TET were reduced to 10 and 7% of insulin, respectively. Thus, there was reduction of NN304 transport, but not to the degree expected. In ISF, there was no reduction in NN304 elimination. Thus, this acylated insulin analog demonstrates blunted kinetics in plasma, and full efficacy in the compartment of action, ISF.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				P. Rossetti, F. Porcellati, N. B. Ricci, P. Candeloro, P. Cioli, G. B. Bolli, and C. G. Fanelli Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans Diabetes, March 1, 2008; 57(3): 746 - 756. [Abstract] [Full Text] [PDF]

				F. M Regan and D. B Dunger Use of new insulins in children Arch. Dis. Child. Ed. Pract., August 1, 2006; 91(2): ep47 - ep53. [Full Text] [PDF]

				T. D. Veenstra, T. P. Conrads, B. L. Hood, A. M. Avellino, R. G. Ellenbogen, and R. S. Morrison Biomarkers: Mining the Biofluid Proteome Mol. Cell. Proteomics, April 1, 2005; 4(4): 409 - 418. [Abstract] [Full Text] [PDF]

				M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, M. K. Dea, E. Kirkman, A. Perianayagam, J. Markussen, and R. N. Bergman Mechanism of Action in Dogs of Slow-Acting Insulin Analog O346 J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2256 - 2262. [Abstract] [Full Text] [PDF]

				M. Hamilton-Wessler, M. Ader, M. K. Dea, D. Moore, M. Loftager, J. Markussen, and R. N. Bergman Mode of Transcapillary Transport of Insulin and Insulin Analog NN304 in Dog Hindlimb: Evidence for Passive Diffusion Diabetes, March 1, 2002; 51(3): 574 - 582. [Abstract] [Full Text] [PDF]